Published Date: Feb-19
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report Asia Pacific Cardiac Pacemaker Market, published by KBV research, the Asia Pacific Cardiac Pacemaker Market would witness market growth of 8.1% CAGR during the forecast period (2018 – 2024).
The Japan market would dominate the Asia Pacific External Cardiac Pacemaker Market by Country 2024, growing at a CAGR of 6.7 % during the forecast period. The China market is expected to witness a CAGR of 10% during (2018 - 2024). Additionally, The India market is expected to witness a CAGR of 10% during (2018 - 2024).
The Hospitals market dominated the Asia Pacific Cardiac Pacemaker Market by End User 2017, thereby, achieving a market value of $1,221.3 million by 2024. The Ambulatory Surgery Centers (ASCs) market is expected to witness a CAGR of 7.7% during (2018 - 2024).
The Implantable Cardiac Pacemakers market dominated the India Cardiac Pacemaker Market by Product 2017 growing at a CAGR of 8.6 % during the forecast period. The External Cardiac Pacemaker market is expected to witness highest CAGR of 10% during (2018 - 2024).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories (U.S.), Boston Scientific Corporation, Biotronik SE & Co. KG, Lepu Medical Technology Co ltd, Cook Medical Group, Medico S.p.A, LivaNova PL, Osypka Medical GmbH, Shree Pacetronix Ltd. and Medline Industries, Inc.
Asia Pacific Cardiac Pacemaker Market Segmentation
By End User
Unique Offerings from KBV Research